Also see: Cisco, CVS: Analysts' New RatingsEditor's Note: Green and red arrows refer to intraday stock price movement. NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES Accretive Health ( AH) numbers lowered at Goldman. Shares of AH now seen reaching $26. Estimates also cut, as the company is seeing higher operating costs. Neutral rating. Brady ( BRC) estimates, target raised at Keybanc. Shares of BRC now seen reaching $44, according to Keybanc. Estimates also increased, as the company is leveraged to positive macro trends. Buy rating. Bristow ( BRS) estimates, target raised at Goldman. Shares of BRS now seen reaching $57. Estimates also increased, as the company is seeing higher sales. Neutral rating. Cisco Systems ( CSCO) estimates upped at Goldman through 2012. Company is boosting margins through cost cuts. Neutral rating and $21 price target. Costco ( COST) estimates, target boosted at Jefferies. Shares of COST now seen reaching $93, according to Jefferies. Estimates also upped, as the company is seeing higher sales and buying back stock. Buy rating. Covidien ( COV) target raised at Morgan Stanley. Shares of COV now seen reaching $63, according to Morgan Stanley. Emerging market growth is accelerating and the company is returning capital to investors. Overweight rating. Computer Sciences ( CSC) numbers cut at Goldman. CSC estimates were reduced through 2013, Goldman Sachs said. Lower expected organic growth will likely weigh on margins. Neutral rating and new $43 price target. Dollar Tree ( DLTR) numbers upped at Jefferies. DLTR estimates were boosted through 2012, Jefferies said. Company could see more traffic, as consumers trade down because of rising gas prices. Buy rating and new $69 price target. DirecTV ( DTV) target increased at Morgan Stanley. DTV target was raised to $57, Morgan Stanley said. Company is seeing better growth in Latin America. Overweight rating. JC Penney ( JCP) numbers boosted at BMO. Shares of JCP now seen reaching $35, according to BMO Capital. Estimates also upped, as the company could buy back even more shares. Market Perform rating. Macy's ( M) price target boosted at Citi. M price target increased to $44 from $32. Strong 1Q11, momentum should carry to 2Q11, Citigroup said. Maintain Buy rating.
Macy's estimates, target boosted at Goldman. Shares of M now seen reaching $32, according to Goldman Sachs. Estimates also upped, as the company is gaining market share. Neutral rating. McDermott ( MDR) estimates, target reduced at UBS. MDR estimates were cut through 2012, UBS said. Company's backlog declined and margins are falling. Buy rating and new $28 price target. Maidenform Brands ( MFB) price target boosted at Citi to $39 from $33. 1Q11 best estimates, guidance beatable, Citigroup said. Maintain Buy rating. Sapient ( SAPE) price target higher at Citi, to $17.25 from $14.75. Underappreciated margin expansion story, Citigroup said. Maintain Buy rating. Symantec ( SYMC) price target higher at Citi, to $24 from $22. Strong revenue in first quarter, driven by storage sales, Citigroup said. Maintain Buy rating. Sysco ( SYY) price target raised at Citi. SYY price target increased to $34 from $30. Strong case volumes drive 3Q11 EPS upside, Citigroup said. Maintain Hold rating. Teva Pharmaceuticals ( TEVA) estimates upped at Morgan Stanley through 2014. Growth should accelerate in the coming quarters. Equal-weight rating. Tesoro ( TSO) estimates, target raised at Oppenheimer. Shares of TSO now seen reaching $28, according to Oppenheimer. Estimates also increased, as the company is seeing higher refining margins. Outperform rating. Wal-Mart ( WMT) estimates increased at Jefferies through 2012, Jefferies said. Broader assortment is helping grocery sales. Buy rating and $61 price target. End of report.